Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19770379

J. Clin. Oncol. 2009 Nov 1 27 31 5213-8

Download in:

View as

Triples

General Info

PMID
19770379